Review article · 2003
Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges
Pharmacogenetics, 13(9), 525–534 · Published 25 August 2003 · DOI 10.1097/00008571-200309000-00001
In brief
“Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges” is a 2003 review article by Julie A. Johnson and John J. Lima, published in Pharmacogenetics. OpenAlex counts 64 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 64
- Most cited in
- 2012 (7)
- Field-weighted impact
- 0.92
- References
- 39
- Authors
- 2
Abstract
The pharmacogenetics literature of drug receptors and effector proteins is in its relative infancy compared to that of drug metabolism pharmacogenetics. Nonetheless, in a short time period, numerous studies have demonstrated that receptor/effector polymorphisms contribute to variable drug response. We review the current status, and list challenges that confront drug target pharmacogenetics before we can… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Johnson, J. A., & Lima, J. J. (2003). Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges. Pharmacogenetics, 13(9), 525–534. https://doi.org/10.1097/00008571-200309000-00001
MLA 9
Johnson, Julie A., and John J. Lima. “Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.” Pharmacogenetics, vol. 13, no. 9, 2003, pp. 525–534. https://doi.org/10.1097/00008571-200309000-00001.
Chicago
Johnson, Julie A. and John J. Lima. 2003. “Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.” Pharmacogenetics 13 (9): 525–534. https://doi.org/10.1097/00008571-200309000-00001.
Harvard
Johnson, J. A. and Lima, J. J. (2003) ‘Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges’, Pharmacogenetics, 13(9), pp. 525–534. doi:10.1097/00008571-200309000-00001.
IEEE
J. A. Johnson and J. J. Lima, “Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges,” Pharmacogenetics, vol. 13, no. 9, pp. 525–534, 2003, doi: 10.1097/00008571-200309000-00001.
BibTeX
@article{johnson2003drug,
title = {{Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges}},
author = {Johnson, Julie A. and Lima, John J.},
journal = {Pharmacogenetics},
year = {2003},
volume = {13},
number = {9},
pages = {525--534},
doi = {10.1097/00008571-200309000-00001},
url = {https://doi.org/10.1097/00008571-200309000-00001}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2012 | 7 | |
| 2013 | 1 | |
| 2015 | 1 | |
| 2016 | 1 | |
| 2018 | 2 | |
| 2020 | 1 | |
| 2025 | 2 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.92: it has been cited 0.92 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- effector proteins
- G protein-coupled receptors
- beta-adrenergic receptors
- non-synonymous polymorphisms
- haplotypes
- signal transduction proteins
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Johnson, J. A., & Lima, J. J. (2003). Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges. Pharmacogenetics, 13(9), 525–534. https://doi.org/10.1097/00008571-200309000-00001
How many times has this paper been cited?
64 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Julie A. Johnson, John J. Lima.
What is the DOI of this paper?
10.1097/00008571-200309000-00001, permanently at https://doi.org/10.1097/00008571-200309000-00001. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.